← All stocks

Stock news timeline · INDOCO

Indoco Remedies

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
12
Bullish
5
Neutral
6
Bearish
1
Active days
7

News timeline

Showing 12 of 12 updates · Newest first

Friday, 18 Sep 20261 update

AI sentiment: Neutral 89% confidence

Indoco Remedies Sets Up Pharma Subsidiary with ₹1L Capital

Indoco Remedies approved setting up Warren Lifesciences Pvt Ltd as a wholly owned subsidiary. The subsidiary aims to boost pharmaceutical manufacturing, with Rs. 100,000 initial capital. Source: ScoutQuest

Friday, 11 Sep 20261 update

AI sentiment: Bullish 85% confidence

Indoco Q4 Income Rises 6.8% to ₹475 Cr; Profit at ₹20.9 Cr

Indoco Remedies Q4 total income at ₹475.6 Cr, up 6.8%. Operating margin stood at 4.4% with ₹20.9 Cr profit. Source: livemint.com

Thursday, 10 Sep 20263 updates

AI sentiment: Bullish 75% confidence

Indoco Remedies: UK MHRA completes CGMP inspection of Goa facility with no critical or major observations.

AI sentiment: Bullish 87% confidence

Indoco Remedies' Goa Plant Gets UK-MHRA Nod, Boosts Global Credibility

Indoco Remedies' Goa facility cleared UK-MHRA inspection with no critical observations, validating its quality standards. The plant contributes ~30% to international business and holds approvals from USFDA, TGA-Australia, and WHO-GMP. Source: BSE

AI sentiment: Neutral 60% confidence

Indoco Promoters Raise Stake to 7.30%

Promoter group of Indoco Remedies acquired 38,930 shares via open market, raising their stake from 7.26% to 7.30%. Acquisition involved Aditi M. Panandikar, Suresh G Kare, Madhura Suresh Kare, and Aruna Suresh Kare. Source: BSE

Monday, 07 Sep 20261 update

AI sentiment: Bearish 93% confidence

Indoco Remedies Falls 2.5% on USFDA Observations at Goa Plant

Indoco Remedies fell 2.5% to Rs 255.40 after USFDA flagged 7 observations at its Goa Plant II. The company plans to respond to USFDA observations; Q1 FY27 net profit stood at Rs 64.9 crore. Source: Business Standard

Saturday, 05 Sep 20262 updates

AI sentiment: Neutral 70% confidence

Indoco Remedies: Goa Plant II Gets Seven Observations From USFDA Inspection. Company Will Provide Detailed Response Soon.

AI sentiment: Neutral 83% confidence

USFDA Flags 7 Issues at Indoco's Goa Plant

USFDA inspected Indoco Remedies' Goa sterile plant, Aug 27-Sep 4, 2026. Seven observations noted in Form 483; company to address and respond. Source: ScoutQuest

Tuesday, 01 Sep 20261 update

AI sentiment: Neutral 89% confidence

Aditi Panandikar Buys 10K Indoco Shares, Promoter Stake Now 5.86%

Aditi M. Panandikar disclosed acquisition of 10,000 Indoco Remedies shares via open market. Post-acquisition, promoter group holds 54,06,671 shares, raising total ownership to 5.86%. Source: BSE

Thursday, 27 Aug 20263 updates

AI sentiment: Bullish 87% confidence

Indoco Remedies to Sell Land for ₹64 Cr, Boosts Capital

Indoco Remedies to sell Mulgaon land for ₹64 crore. The deal signals asset monetization to free up capital. Source: Livesquawk

AI sentiment: Bullish 87% confidence

Indoco Remedies: Signs Deal To Sell Mulgaon Land For ₹64 Crore.

AI sentiment: Neutral 93% confidence

Indoco Remedies Sells Plot for ₹64 Cr; No Business Impact

Indoco Remedies sold a 2,876.08 sq. meter plot in Mahal Industrial Estate for ₹64 crore. The sale to Kalpataru Townships won't impact business operations or constitute a major undertaking. Source: BSE